ilikefinance

“Amgen’s Q4 Earnings: Strong Pipeline and Label Expansions Make It a Must-Buy Stock!”

Amgen Inc.’s Q4 2024 Earnings: A Delicious Surprise A Satisfying Quarter Indeed Amgen Inc. recently served up a delectable treat for investors with its Q4 2024 earnings report. The biotech giant not only beat expectations but did so with flair, showcasing an impressive 11% year-over-year revenue growth and a mouth-watering 13% increase in earnings per…

Read More

“Uncovering the Heart of Vishay Intertechnology Inc.’s Q4 2024 Earnings Call: A Deep Dive into the Emotions and Insights Shared”

In the recent Vishay Intertechnology Q4 2024 Earnings Conference Call, key executives including EVP Peter Henrici, President & CEO Joel Smejkal, and CFO Dave McConnell provided insights into the company’s financial performance and future outlook. The call took place on February 5, 2025, at 9:00 AM ET, with participants from JP Morgan and Bank of…

Read More

“Unpacking CDW Corporation’s Q4 2024 Earnings Call: Insights and Highlights”

CDW Corporation (NASDAQ:CDW) Q4 2024 Earnings Conference Call Overview Company Participants Steve O’Brien – Vice President-Investor Relations Christine Leahy – Chair and Chief Executive Officer Albert Miralles – Senior Vice President and Chief Financial Officer Conference Call Participants Amit Daryanani – Evercore ISI Samik Chatterjee – JPMorgan Chase & Co Ruplu Bhattacharya – Bank of…

Read More

“Discover the Hidden Gems: 3 Fallen Angels with Ultra High-Yield Dividends That Are Attracting Fast Money Investors”

Investors’ Love for Dividend Stocks Investors love dividend stocks, especially the high-yield variety, because they offer a significant income stream and have massive total return potential. Total return includes interest, capital gains, dividends, and distributions realized over time. In other words, the total return on an investment or a portfolio consists of income and stock…

Read More

“Breaking News: Pomerantz Law Firm Launches Investigation on Behalf of Investors – Don’t Miss Out!”

Investigation on XBiotech Inc. by Pomerantz LLP Overview On February 5, 2025, Pomerantz LLP announced that it is investigating claims on behalf of investors of XBiotech Inc.(“XBiotech” or the “Company”) (NASDAQ:XBIT). Investors who have invested in XBiotech are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. What is XBiotech Inc.? XBiotech Inc. is…

Read More

“Unlock Your Inner Creativity: A Guide to Finding Inspiration on YouTube”

Jessica Reif Erlich, senior media and entertainment analyst at BofA Securities Disney’s Future and More Insights from an Industry Expert It’s always interesting to hear from industry experts about their thoughts on major players in the market. Jessica Reif Erlich, a senior media and entertainment analyst at BofA Securities, recently shared her insights on Disney…

Read More